ProQR Therapeutics N.V. (FRA:0PQ)
Germany
· Delayed Price · Currency is EUR 1.783
+0.103 (6.13%)
Last updated: Dec 5, 2025, 8:02 AM CET
ProQR Therapeutics Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 106.88 | 149.41 | 118.93 | 94.78 | 187.52 | 75.84 | Upgrade
|
| Cash & Short-Term Investments | 106.88 | 149.41 | 118.93 | 94.78 | 187.52 | 75.84 | Upgrade
|
| Cash Growth | 19.55% | 25.63% | 25.48% | -49.46% | 147.27% | -32.26% | Upgrade
|
| Accounts Receivable | - | - | - | 56.25 | - | - | Upgrade
|
| Other Receivables | 2.55 | 2.03 | 1.27 | 0.98 | 0.82 | 0.8 | Upgrade
|
| Receivables | 2.55 | 2.03 | 1.27 | 57.24 | 0.82 | 0.8 | Upgrade
|
| Prepaid Expenses | 1.9 | 2.41 | 0.79 | 2.45 | 3.14 | 3.38 | Upgrade
|
| Total Current Assets | 111.33 | 153.85 | 120.99 | 154.46 | 191.48 | 80.02 | Upgrade
|
| Property, Plant & Equipment | 13.02 | 14.11 | 16.9 | 16.24 | 17.47 | 18.6 | Upgrade
|
| Long-Term Investments | - | - | - | 0.62 | 0.63 | 0.11 | Upgrade
|
| Total Assets | 124.35 | 167.96 | 137.88 | 171.32 | 209.58 | 98.73 | Upgrade
|
| Accounts Payable | 0.31 | 0.02 | 1.54 | 0.39 | 0.19 | 0.22 | Upgrade
|
| Accrued Expenses | 0.12 | 1.48 | 1.66 | 1.12 | 1.23 | 6.15 | Upgrade
|
| Current Portion of Long-Term Debt | 4.8 | 4.58 | - | 2.5 | 4.77 | 1.14 | Upgrade
|
| Current Portion of Leases | 1.67 | 1.57 | 1.61 | 1.39 | 1.53 | 1.26 | Upgrade
|
| Current Unearned Revenue | 17.39 | 21.94 | 20.57 | 5.64 | 5.12 | 0.7 | Upgrade
|
| Other Current Liabilities | 8.84 | 9.32 | 8.82 | 9.95 | 14.76 | 0.84 | Upgrade
|
| Total Current Liabilities | 33.14 | 38.9 | 34.2 | 20.99 | 27.6 | 10.3 | Upgrade
|
| Long-Term Debt | - | - | 4.29 | 4.27 | 39.32 | 16.19 | Upgrade
|
| Long-Term Leases | 10.02 | 11.07 | 13.83 | 13.81 | 14.75 | 15.69 | Upgrade
|
| Long-Term Unearned Revenue | 24.13 | 29.43 | 44.17 | 65.57 | 14.69 | - | Upgrade
|
| Total Liabilities | 67.28 | 79.4 | 96.49 | 104.64 | 96.35 | 42.18 | Upgrade
|
| Common Stock | 4.31 | 4.31 | 3.37 | 3.37 | 3 | 2.17 | Upgrade
|
| Additional Paid-In Capital | 483.88 | 483.81 | 412.89 | 412.54 | 398.31 | 288.76 | Upgrade
|
| Retained Earnings | -458.71 | -427.16 | -400.85 | -379.11 | -317.77 | -257.75 | Upgrade
|
| Comprehensive Income & Other | 27.59 | 27.6 | 25.98 | 30.26 | 30.3 | 23.92 | Upgrade
|
| Total Common Equity | 57.07 | 88.56 | 41.39 | 67.07 | 113.83 | 57.09 | Upgrade
|
| Minority Interest | - | - | - | -0.38 | -0.6 | -0.55 | Upgrade
|
| Shareholders' Equity | 57.07 | 88.56 | 41.39 | 66.68 | 113.23 | 56.55 | Upgrade
|
| Total Liabilities & Equity | 124.35 | 167.96 | 137.88 | 171.32 | 209.58 | 98.73 | Upgrade
|
| Total Debt | 16.49 | 17.22 | 19.73 | 21.97 | 60.37 | 34.28 | Upgrade
|
| Net Cash (Debt) | 90.39 | 132.19 | 99.19 | 72.8 | 127.15 | 41.56 | Upgrade
|
| Net Cash Growth | 25.54% | 33.27% | 36.24% | -42.74% | 205.94% | -57.76% | Upgrade
|
| Net Cash Per Share | 0.87 | 1.54 | 1.22 | 1.02 | 1.98 | 0.83 | Upgrade
|
| Filing Date Shares Outstanding | 105.35 | 105.21 | 81.35 | 80.82 | 71.29 | 50.2 | Upgrade
|
| Total Common Shares Outstanding | 105.35 | 105.21 | 81.35 | 80.82 | 71.29 | 50.2 | Upgrade
|
| Working Capital | 78.2 | 114.94 | 86.78 | 133.47 | 163.89 | 69.72 | Upgrade
|
| Book Value Per Share | 0.54 | 0.84 | 0.51 | 0.83 | 1.60 | 1.14 | Upgrade
|
| Tangible Book Value | 57.07 | 88.56 | 41.39 | 67.07 | 113.83 | 57.09 | Upgrade
|
| Tangible Book Value Per Share | 0.54 | 0.84 | 0.51 | 0.83 | 1.60 | 1.14 | Upgrade
|
| Buildings | - | 23.79 | 24.78 | 22.86 | 22.23 | 21.64 | Upgrade
|
| Machinery | - | 6.82 | 5.91 | 4.91 | 4.25 | 3.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.